Anna M Wehry1, Robert K McNamara2, Caleb M Adler3, James C Eliassen3, Paul Croarkin4, Michael A Cerullo2, Melissa P DelBello2, Jeffrey R Strawn2. 1. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, 260 Stetson Street, Suite 3200, ML 0559, Cincinnati, OH 45267-0559, USA. Electronic address: wehryam@mail.uc.edu. 2. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, 260 Stetson Street, Suite 3200, ML 0559, Cincinnati, OH 45267-0559, USA. 3. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, 260 Stetson Street, Suite 3200, ML 0559, Cincinnati, OH 45267-0559, USA; Center for Imaging Research, University of Cincinnati, College of Medicine, Cincinnati, OH, USA. 4. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Depressive and anxiety disorders are among the most frequently occurring psychiatric conditions in children and adolescents and commonly present occur together. Co-occurring depression and anxiety is associated with increased functional impairment and suicidality compared to depression alone. Despite this, little is known regarding the neurostructural differences between anxiety disorders and major depressive disorder (MDD). Moreover, the neurophysiologic impact of the presence of anxiety in adolescents with MDD is unknown. METHODS: Using voxel-based morphometry, gray matter volumes were compared among adolescents with MDD (and no co-morbid anxiety disorders, n=14), adolescents with MDD and co-morbid anxiety ("anxious depression," n=12), and healthy comparison subjects (n=41). RESULTS: Patients with anxious depression exhibited decreased gray matter volumes in the dorsolateral prefrontal cortex (DLPFC) compared to patients with MDD alone. Compared to healthy subjects, adolescents with anxious depression had increased gray matter volumes in the pre- and post-central gyri. LIMITATIONS: The current sample size was small and precluded an analysis of multiple covariates which may influence GMV. CONCLUSIONS: Gray matter deficits in the DLPFC in youth with anxious depression compared to patients with MDD and no co-occurring anxiety may reflect the more severe psychopathology in these patients. Additionally, the distinct gray matter fingerprints of MDD and anxious depression (compared to healthy subjects) suggest differing neurophysiologic substrates for these conditions, though the etiology and longitudinal trajectory of the differences remain to be determined.
BACKGROUND:Depressive and anxiety disorders are among the most frequently occurring psychiatric conditions in children and adolescents and commonly present occur together. Co-occurring depression and anxiety is associated with increased functional impairment and suicidality compared to depression alone. Despite this, little is known regarding the neurostructural differences between anxiety disorders and major depressive disorder (MDD). Moreover, the neurophysiologic impact of the presence of anxiety in adolescents with MDD is unknown. METHODS: Using voxel-based morphometry, gray matter volumes were compared among adolescents with MDD (and no co-morbid anxiety disorders, n=14), adolescents with MDD and co-morbid anxiety ("anxious depression," n=12), and healthy comparison subjects (n=41). RESULTS:Patients with anxious depression exhibited decreased gray matter volumes in the dorsolateral prefrontal cortex (DLPFC) compared to patients with MDD alone. Compared to healthy subjects, adolescents with anxious depression had increased gray matter volumes in the pre- and post-central gyri. LIMITATIONS: The current sample size was small and precluded an analysis of multiple covariates which may influence GMV. CONCLUSIONS:Gray matter deficits in the DLPFC in youth with anxious depression compared to patients with MDD and no co-occurring anxiety may reflect the more severe psychopathology in these patients. Additionally, the distinct gray matter fingerprints of MDD and anxious depression (compared to healthy subjects) suggest differing neurophysiologic substrates for these conditions, though the etiology and longitudinal trajectory of the differences remain to be determined.
Authors: Kevin Hilbert; Daniel S Pine; Markus Muehlhan; Ulrike Lueken; Susann Steudte-Schmiedgen; Katja Beesdo-Baum Journal: Psychiatry Res Date: 2015-10-13 Impact factor: 3.222
Authors: Bhedita J Seewoo; Jennifer Rodger; Mark A Demitrack; Karen L Heart; John D Port; Jeffrey R Strawn; Paul E Croarkin Journal: Int J Neuropsychopharmacol Date: 2022-08-16 Impact factor: 5.678
Authors: Eric T Dobson; Paul E Croarkin; Heidi K Schroeder; Sara T Varney; Sarah A Mossman; Kim Cecil; Jeffrey R Strawn Journal: J Affect Disord Date: 2020-11-11 Impact factor: 4.839
Authors: Ni Ni Soe; Daniel J Wen; Joann S Poh; Yue Li; Birit F P Broekman; Helen Chen; Yap Seng Chong; Kenneth Kwek; Seang-Mei Saw; Peter D Gluckman; Michael J Meaney; Anne Rifkin-Graboi; Anqi Qiu Journal: PLoS One Date: 2016-04-13 Impact factor: 3.240
Authors: Dongrong Xu; Guojun Xu; Zhiyong Zhao; M Elizabeth Sublette; Jeffrey M Miller; J John Mann Journal: Hum Brain Mapp Date: 2021-07-27 Impact factor: 5.038